|drug1025||Dexamethasone 2 MG/ML Wiki||1.00|
|drug2034||Methylprednisolone Injection Wiki||1.00|
|D003141||Communicable Diseases NIH||0.07|
There is one clinical trial.
This is a randomized controlled trial of the efficacy and safety evaluation of oral administration of Bromhexine hydrochloride for the prevention of SARS-CoV-2 infection and COVID-19 disease in medical personnel assisting patients with a new coronavirus disease
Description: Negative PCR of SARS-CoV-2 and the absence of clinical manifestations of COVID-19 infection in individuals taking Bromhexine hydrochloride 4 weeks after randomization.Measure: Polymerase chain reaction (PCR) Time: 4 weeks after randomization
Description: Time to clinical symptoms of a respiratory infection with positive PCR SARS-CoV-2Measure: Time to symptoms Time: 14 days after last contact
Description: Time to detect positive SARS-CoV-2 PCRMeasure: Time to positive PCR Time: 14 days after last contact
Description: The number of asymptomatic cases of SARS-CoV-2 infectionMeasure: Number of cases Time: 14 days after last contact
Description: The number of mild, moderate and severe forms of the disease COVID-19 with Bromhexine hydrochlorideMeasure: Case severity Time: 14 days after last contact
Description: Evaluation of adverse eventsMeasure: Drug tolerance Time: 14 days after last contact
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports